Go Pro

Entrada Therapeutics (TRDA) Institutional Ownership

Entrada Therapeutics logo
$7.36 -0.35 (-4.54%)
Closing price 06/30/2026 04:00 PM Eastern
Extended Trading
$7.36 0.00 (0.00%)
As of 06/30/2026 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Entrada Therapeutics (NASDAQ:TRDA)

Current
Institutional Ownership
Percentage
86.39%
Number of
Institutional Buyers
(last 12 months)
64
Total
Institutional Inflows
(last 12 months)
$25.91M
Number of
Institutional Sellers
(last 12 months)
20
Total
Institutional Outflows
(last 12 months)
$15.24M
Get TRDA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Entrada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

TRDA Institutional Buying and Selling by Quarter

Entrada Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026Bank of America Corp DE39,212$495K0.0%-40.6%0.101%
5/18/2026ADAR1 Capital Management LLC30,500$385K0.0%N/A0.079%
5/16/2026The Manufacturers Life Insurance Company 70,656$892K0.0%+25.0%0.182%
5/16/2026Quantinno Capital Management LP71,018$896K0.0%+4.9%0.183%
5/14/2026Renaissance Technologies LLC202,084$2.55M0.0%-20.0%0.521%
5/7/2026Dimensional Fund Advisors LP324,471$4.09M0.0%+18.7%0.836%
5/6/2026Allspring Global Investments Holdings LLC19,465$246K0.0%+11.3%0.050%
5/5/2026Bank of New York Mellon Corp76,427$965K0.0%-3.7%0.197%
4/30/2026Hsbc Holdings PLC38,137$472K0.0%+83.1%0.098%
2/19/2026Invesco Ltd.41,033$422K0.0%+41.1%0.107%
2/18/2026XTX Topco Ltd117,668$1.21M0.0%+26.4%0.308%
2/18/2026Wellington Management Group LLP1,044,758$10.74M0.0%+9.5%2.734%
2/18/2026Sphera Funds Management LTD.110,942$1.14M0.2%N/A0.290%
2/18/2026Quadrature Capital Ltd20,318$209K0.0%+13.5%0.053%
2/18/2026Millennium Management LLC497,695$5.12M0.0%-40.5%1.302%
2/18/2026Balyasny Asset Management L.P.14,017$144K0.0%N/A0.037%
2/18/2026Baker BROS. Advisors LP5,072,730$52.15M0.3%+4.3%13.272%
2/18/20265AM Venture Management LLC4,056,379$41.70M13.1%-4.7%10.613%
2/17/2026AQR Capital Management LLC26,254$270K0.0%+87.6%0.069%
2/17/2026Cantor Fitzgerald L. P.57,000$586K0.0%-15.3%0.149%
2/17/2026Trexquant Investment LP121,280$1.25M0.0%-1.3%0.317%
2/17/2026Price T Rowe Associates Inc. MD327,423$3.37M0.0%-9.2%0.857%
2/17/2026Public Employees Retirement System of Ohio37,502$386K0.0%+33.0%0.098%
2/17/2026Russell Investments Group Ltd.11,571$119K0.0%+31.4%0.030%
2/17/2026ExodusPoint Capital Management LP37,430$385K0.0%N/A0.098%
2/17/2026Magnetar Financial LLC13,373$137K0.0%N/A0.035%
2/16/2026Barclays PLC67,147$690K0.0%+10.7%0.176%
2/13/2026Marshall Wace LLP20,657$212K0.0%N/A0.054%
2/13/2026Walleye Capital LLC13,534$139K0.0%-86.0%0.035%
2/13/2026Jacobs Levy Equity Management Inc.362,786$3.73M0.0%+14.9%0.949%
2/13/2026Charles Schwab Investment Management Inc.221,269$2.28M0.0%+19.4%0.579%
2/13/2026State Street Corp508,789$5.23M0.0%+2.0%1.331%
2/13/2026Dynamic Technology Lab Private Ltd25,302$260K0.1%N/A0.066%
2/13/2026Wells Fargo & Company MN32,163$331K0.0%+48.8%0.084%
2/12/2026MetLife Investment Management LLC17,802$183K0.0%+148.6%0.047%
2/12/2026Renaissance Technologies LLC252,635$2.60M0.0%-57.5%0.661%
2/12/2026Dimensional Fund Advisors LP273,378$2.81M0.0%-30.7%0.715%
2/12/2026Great Lakes Advisors LLC43,268$445K0.0%+5.5%0.113%
2/11/2026Los Angeles Capital Management LLC45,952$472K0.0%-11.8%0.120%
2/10/2026Goldman Sachs Group Inc.205,173$2.11M0.0%-7.7%0.537%
Trump just signed it (Ad)

A recent policy development is drawing attention from income-focused investors. According to one analyst, changes behind the scenes may be opening the door to new cash-flow opportunities designed to generate regular monthly income — without requiring investors to pick individual stocks or predict market direction. In a new briefing, he explains how the structure works and what investors should understand before considering it.tc pixel

Learn how these income opportunities are structured
2/10/2026Intech Investment Management LLC11,929$123K0.0%-13.8%0.031%
2/9/2026Geode Capital Management LLC639,947$6.58M0.0%-0.8%1.674%
2/9/2026Royce & Associates LP247,147$2.54M0.0%-28.5%0.647%
1/15/2026Allspring Global Investments Holdings LLC17,495$176K0.0%+9.8%0.046%
1/1/2026JPMorgan Chase & Co.133,878$776K0.0%+735.0%0.350%
12/1/2025Cantor Fitzgerald L. P.67,334$391K0.0%N/A0.176%
11/17/2025Jacobs Levy Equity Management Inc.315,810$1.83M0.0%+43.1%0.826%
11/17/2025NewEdge Advisors LLC14,167$82K0.0%N/A0.037%
11/17/2025XTX Topco Ltd93,079$540K0.0%N/A0.244%
11/17/2025Sherbrooke Park Advisers LLC18,573$108K0.1%N/A0.049%
11/17/2025Qube Research & Technologies Ltd287,873$1.67M0.0%+115.3%0.753%
11/17/2025Prelude Capital Management LLC25,754$149K0.0%N/A0.067%
11/17/2025Public Employees Retirement System of Ohio28,202$164K0.0%+88.0%0.074%
11/17/2025Millennium Management LLC836,609$4.85M0.0%+391.2%2.189%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.13,108$76K0.0%-14.8%0.034%
11/17/2025Jain Global LLC11,954$69K0.0%N/A0.031%
11/17/2025Citadel Advisors LLC335,741$1.95M0.0%+234.5%0.878%
11/17/2025Bank of America Corp DE126,448$733K0.0%+246.7%0.331%
11/17/2025Cantor Fitzgerald L. P.67,334$391K0.0%N/A0.176%
11/17/2025Algert Global LLC129,812$753K0.0%N/A0.340%
11/17/2025Alliancebernstein L.P.24,320$141K0.0%+7.1%0.064%
11/17/2025Ameriprise Financial Inc.69,926$406K0.0%+55.6%0.183%
11/14/2025Occudo Quantitative Strategies LP29,486$171K0.0%+190.6%0.077%
11/14/2025Two Sigma Investments LP93,194$541K0.0%N/A0.244%
11/14/2025Bridgeway Capital Management LLC40,000$232K0.0%N/A0.105%
11/13/2025BNP Paribas Financial Markets148,212$860K0.0%+4,767.4%0.388%
11/13/2025Russell Investments Group Ltd.8,808$51K0.0%+72.7%0.023%
11/12/2025Dimensional Fund Advisors LP394,279$2.29M0.0%-7.0%1.032%
11/12/2025Royce & Associates LP345,507$2.00M0.0%+54.8%0.904%
11/12/2025Intech Investment Management LLC13,843$80K0.0%-21.8%0.036%
11/10/2025TD Asset Management Inc37,788$219K0.0%-20.9%0.099%
11/10/2025AXQ Capital LP11,570$67K0.0%N/A0.030%
11/7/2025GSA Capital Partners LLP55,960$325K0.0%N/A0.147%
11/7/2025JPMorgan Chase & Co.133,878$776K0.0%+735.0%0.352%
11/3/2025AlphaQuest LLC6,475$38K0.0%-83.7%0.017%
11/3/2025Great Lakes Advisors LLC41,029$238K0.0%N/A0.108%
10/29/2025Inscription Capital LLC11,835$69K0.0%N/A0.031%
8/19/2025State of Wyoming7,575$51K0.0%+130.9%0.020%
8/15/2025Man Group plc16,805$113K0.0%N/A0.044%
8/15/2025IHT Wealth Management LLC10,700$72K0.0%N/A0.028%
8/15/2025Bank of America Corp DE36,473$245K0.0%+35.6%0.096%
8/15/20255AM Venture Management LLC4,308,379$28.95M11.1%-2.3%11.326%
8/15/2025Ameriprise Financial Inc.44,946$302K0.0%+9.6%0.118%
8/14/2025Jane Street Group LLC51,158$344K0.0%N/A0.134%
8/14/2025Occudo Quantitative Strategies LP10,148$68K0.0%N/A0.027%
8/14/2025Qube Research & Technologies Ltd133,730$899K0.0%+435.1%0.352%
8/14/2025Federated Hermes Inc.96,686$650K0.0%-2.1%0.254%
8/13/2025Walleye Capital LLC17,409$117K0.0%N/A0.046%
8/13/2025First Trust Advisors LP75,120$505K0.0%+3.6%0.197%
8/13/2025Invesco Ltd.22,393$150K0.0%+34.2%0.059%
Trump just signed it (Ad)

A recent policy development is drawing attention from income-focused investors. According to one analyst, changes behind the scenes may be opening the door to new cash-flow opportunities designed to generate regular monthly income — without requiring investors to pick individual stocks or predict market direction. In a new briefing, he explains how the structure works and what investors should understand before considering it.tc pixel

Learn how these income opportunities are structured
8/13/2025Arrowstreet Capital Limited Partnership102,008$685K0.0%-17.7%0.268%
8/13/2025Virtus Investment Advisers LLC11,979$80K0.0%+32.1%0.031%
8/12/2025Prudential Financial Inc.28,340$190K0.0%+23.4%0.075%
8/12/2025American Century Companies Inc.75,094$505K0.0%+10.8%0.197%
8/12/2025Rhumbline Advisers39,095$263K0.0%+8.3%0.103%
8/12/2025Dynamic Technology Lab Private Ltd24,734$166K0.0%N/A0.065%
8/8/2025Intech Investment Management LLC17,702$119K0.0%+15.7%0.047%
8/8/2025Geode Capital Management LLC631,554$4.25M0.0%+7.2%1.664%
8/7/2025Los Angeles Capital Management LLC44,632$300K0.0%+60.6%0.118%
8/5/2025Corton Capital Inc.28,755$193K0.2%N/A0.076%


TRDA Institutional Ownership - Frequently Asked Questions

During the previous two years, 103 institutional investors and hedge funds held shares of Entrada Therapeutics. The most heavily invested institutionals were MPM Asset Management LLC ($75.75M), Baker BROS. Advisors LP ($52.15M), 5AM Venture Management LLC ($41.70M), Janus Henderson Group PLC ($36.01M), FMR LLC ($27.86M), Vanguard Group Inc. ($25.32M), and Merck & Co. Inc. ($15.73M).Learn more on Entrada Therapeutics' institutional investors.

86.39% of Entrada Therapeutics' stock is owned by institutional investors. Learn more on TRDA's institutional investor holdings.

Of the 92 institutional investors that purchased Entrada Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Merck & Co. Inc. ($1.74M), Millennium Management LLC ($666.29K), Janus Henderson Group PLC ($530.87K), Qube Research & Technologies Ltd ($262.88K), JPMorgan Chase & Co. ($260.35K), Vanguard Group Inc. ($241.05K), and Citadel Advisors LLC ($235.38K).

Institutional investors have bought a total of 3,718,314 shares in the last 24 months. This purchase volume represents approximately $25.91M in transactions.

Of the 20 institutional investors that sold Entrada Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Renaissance Technologies LLC ($392.22K), Millennium Management LLC ($338.91K), 5AM Venture Management LLC ($300K), Dimensional Fund Advisors LP ($150.61K), Royce & Associates LP ($98.36K), Walleye Capital LLC ($83.15K), and AlphaQuest LLC ($33.15K).

Institutional investors have sold a total of 1,541,570 shares in the last 24 months. This volume of shares sold represents approximately $15.24M in transactions.



This page (NASDAQ:TRDA) was last updated on 7/1/2026 by MarketBeat.com Staff.
From Our Partners